Your browser doesn't support javascript.
loading
Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.
Rojek, Alexandra E; Kline, Justin P; Feinberg, Nicholas; Appelbaum, Daniel E; Pu, Yonglin; Derman, Benjamin A; Jakubowiak, Andrzej; Kosuri, Satyajit; Liu, Hongtao; Nawas, Mariam T; Smith, Sonali M; Bishop, Michael R; Riedell, Peter A.
Affiliation
  • Rojek AE; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL.
  • Kline JP; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Feinberg N; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL.
  • Appelbaum DE; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL.
  • Pu Y; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL.
  • Derman BA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Jakubowiak A; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Kosuri S; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Liu H; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Nawas MT; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Smith SM; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL.
  • Bishop MR; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.
  • Riedell PA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL. Electronic address: Peter.Riedell@bsd.uchicago.edu.
Clin Lymphoma Myeloma Leuk ; 24(2): 83-93, 2024 02.
Article in En | MEDLINE | ID: mdl-37827881
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: Israel
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Large B-Cell, Diffuse Limits: Humans Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: Israel